Varahram Shahryari

Department of Urology, University of California San Francisco

Affiliated withUniversity of California San Francisco VA Medical Center and UCSF

Research Area

Medicine

Biography

Varahram Shahryari has not added Biography.
If you are Varahram Shahryari and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 16	2015
Publication title Cited by 17	2016

Other Publications

Article	Year
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis\| PubMed ID: 19221000	2009
Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy. The Journal of urology\| PubMed ID: 19237173	2009
Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer\| PubMed ID: 19885928	2010
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer research\| PubMed ID: 20332239	2010
Cytochrome P450 17 (CYP17) is involved in endometrial cancinogenesis through apoptosis and invasion pathways. Molecular carcinogenesis\| PubMed ID: 20886547	2011
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21159887	2011
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer research\| PubMed ID: 21330408	2011
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis\| PubMed ID: 21349819	2011
Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21836020	2011
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer research\| PubMed ID: 21852381	2011
MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis\| PubMed ID: 22049531	2012
Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Molecular cancer therapeutics\| PubMed ID: 22057916	2012
Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. Carcinogenesis\| PubMed ID: 22159223	2012
Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PloS one\| PubMed ID: 22347428	2012
miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer research\| PubMed ID: 22552290	2012
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PloS one\| PubMed ID: 22928040	2012
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PloS one\| PubMed ID: 23056431	2012
miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer research\| PubMed ID: 23074286	2012
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23147995	2013
Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PloS one\| PubMed ID: 23189187	2012
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PloS one\| PubMed ID: 23226455	2012
MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PloS one\| PubMed ID: 23383207	2013
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PloS one\| PubMed ID: 23554959	2013
Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells. Molecular cancer therapeutics\| PubMed ID: 23580416	2013
MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases. PloS one\| PubMed ID: 24223753	2013
Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. The Journal of biological chemistry\| PubMed ID: 24616104	2014
Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. Molecular cancer therapeutics\| PubMed ID: 24817628	2014
Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine\| PubMed ID: 25027399	2014
Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer research\| PubMed ID: 25600645	2015
Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways. Oncotarget\| PubMed ID: 25797254	2015
Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Oncotarget\| PubMed ID: 25860934	2015
CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC cancer\| PubMed ID: 26626260	2015